We would like to thank the participants and their legal representatives for their participation in the study. The authors thank all of the field and laboratory technical staff who helped with participant recruitment and follow-up, sample processing, and testing, as well as the regulatory and administrative staff who helped during the study and the global dengue purified inactivated vaccine (DPIV) program team. We also want to thank the following persons who contributed to the study: Adrienne Guignard, Meng Shi, Lucian Jayasuria, Vinaykumar Nandimath, and Anand Harpalani. We also thank the Business & Decision Life Sciences platform for editorial assistance and manuscript coordination on behalf of GSK. Janne Tys (Business & Decision Life Sciences on behalf of GSK) coordinated the manuscript development and editorial support. Esther van de Vosse provided medical writing support.
World Health Organization , 2009. Dengue Guidelines for Diagnosis, Treatment, Prevention and Control: New Edition. Report No.: WHO/HTM/NTD/DEN/2009.1. Geneva, Switzerland: WHO. Available at: https://apps.who.int/iris/bitstream/handle/10665/44188/9789241547871_eng.pdf. Accessed February 2, 2021.
Stanaway JD et al., 2016. The global burden of dengue: an analysis from the Global Burden of Disease Study 2013. Lancet Infect Dis 16: 712–723.
World Health Organization , 2020. Dengue and Severe Dengue. Geneva, Switzerland: WHO. Available at: https://www.who.int/news-room/fact-sheets/detail/dengue-and-severe-dengue. Accessed February 2, 2021.
World Health Organization , 2020. Global Strategy for Dengue Prevention and Control. 2012–2020. Geneva, Switzerland: WHO. Available at: https://apps.who.int/iris/bitstream/handle/10665/75303/9789241504034_eng.pdf. Accessed February 2, 2021.
Brady OJ, Gething PW, Bhatt S, Messina JP, Brownstein JS, Hoen AG, Moyes CL, Farlow AW, Scott TW, Hay SI, 2012. Refining the global spatial limits of dengue virus transmission by evidence-based consensus. PLoS Negl Trop Dis 6: e1760.
International Council for Harmonization , 2016. ICH Harmonised Guideline Integrated Addendum to ICH E6(R1): Guideline for Good Clinical Practice ICH E6(R2) ICH Consensus Guideline. Geneva, Switzerland: ICH. Available at: https://database.ich.org/sites/default/files/E6_R2_Addendum.pdf. Accessed April 26, 2021.
International Federation of Red Cross and Red Crescent Societies (IFRC) , 2018. Sri Lanka/Dengue DREF Final Report (MDRLK007). Report No.: MDRLK007. Geneva, Switzerland: IFRC. Available at: https://reliefweb.int/report/sri-lanka/sri-lanka-dengue-dref-final-report-mdrlk007. Accessed February 9, 2021.
Tam CC, Tissera H, de Silva AM, de Silva AD, Margolis HS, Amarasinge A, 2013. Estimates of dengue force of infection in children in Colombo, Sri Lanka. PLoS Negl Trop Dis 7: e2259.
Tissera H, Amarasinghe A, de Silva AD, Kariyawasam P, Corbett KS, Katzelnick L, Tam C, Letson GW, Margolis HS, de Silva AM, 2014. Burden of dengue infection and disease in a pediatric cohort in urban Sri Lanka. Am J Trop Med Hyg 91: 132–137.
Ministry of Health - Epidemiology Unit - Sri Lanka , 2019. Distribution of Notification (H399). Dengue Cases by Month. Colombo, Sri Lanka: Ministry of Health. Available at: https://www.epid.gov.lk/web/index.php?option=com_casesanddeaths&Itemid=448&lang=en#. Accessed February 9, 2021.
Messer WB, Gubler DJ, Harris E, Sivananthan K, de Silva AM, 2003. Emergence and global spread of a dengue serotype 3, subtype III virus. Emerg Infect Dis 9: 800–809.
Kanakaratne N, Wahala WM, Messer WB, Tissera HA, Shahani A, Abeysinghe N, de Silva AM, Gunasekera M, 2009. Severe dengue epidemics in Sri Lanka, 2003–2006. Emerg Infect Dis 15: 192–199.
Bodinayake CK et al., 2018. Evaluation of the WHO 2009 classification for diagnosis of acute dengue in a large cohort of adults and children in Sri Lanka during a dengue-1 epidemic. PLoS Negl Trop Dis 12: e0006258.
Raut R et al., 2019. Dengue type 1 viruses circulating in humans are highly infectious and poorly neutralized by human antibodies. Proc Natl Acad Sci USA 116: 227–232.
Tomashek KM et al., 2017. Clinical and epidemiologic characteristics of dengue and other etiologic agents among patients with acute febrile illness, Puerto Rico, 2012–2015. PLoS Negl Trop Dis 11: e0005859.
Low JGH et al., 2011. The early clinical features of dengue in adults: challenges for early clinical diagnosis. PLoS Negl Trop Dis 5: e1191.
Tukasan C, Furlan NB, Estofolete CF, Nogueira ML, da Silva NS, 2017. Evaluation of the importance of fever with respect to dengue prognosis according to the 2009 WHO classification: a retrospective study. BMC Infect Dis 17: 6.